@article{8598765,
  abstract     = {{Background: Idiopathic Intracranial Hypertension (IIH) is characterized by an elevation of intracranial pressure (ICP no identifiable cause. The aetiology remains largely unknown, however observations made in a number of recent clinical studies are increasing the understanding of the disease and now provide the basis for evidence-based treatment strategies. 
Methods: The Embase, CDSR, CENTRAL, DARE and MEDLINE databases were searched up to 1st June 2018. We analyzed randomized controlled trials and systematic reviews that investigate IIH. 
Results: Diagnostic uncertainty, headache morbidity and visual loss are among the highest concerns of clinicians and patients in this disease area. Research in this field is infrequent due to the rarity of the disease and the lack of understanding of the underlying pathology. 
Conclusions: This European Headache Federation consensus paper provides evidence-based recommendations and practical advice on the investigation and management of IIH.}},
  articleno    = {{93}},
  author       = {{Hoffmann, Jan and Mollan, Susan P and Paemeleire, Koen and Lampl, Christian and Jensen, Rigmor H and Sinclair, Alexandra J}},
  issn         = {{1129-2369}},
  journal      = {{JOURNAL OF HEADACHE AND PAIN}},
  keywords     = {{OPTIC-NERVE SHEATH,LAPAROSCOPIC-SLEEVE-GASTRECTOMY,TRANSVERSE SINUS STENOSIS,QUALITY-OF-LIFE,PSEUDOTUMOR CEREBRI,CEREBROSPINAL-FLUID,ASYMMETRIC PAPILLEDEMA,MILD PAPILLEDEMA,CHOROID-PLEXUS,WEIGHT-LOSS}},
  language     = {{eng}},
  pages        = {{15}},
  title        = {{European Headache Federation guideline on idiopathic intracranial hypertension}},
  url          = {{http://doi.org/10.1186/s10194-018-0919-2}},
  volume       = {{19}},
  year         = {{2018}},
}

Altmetric

View in Altmetric

Web of Science

Times cited: